X-131081799-G-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_144967.4(ARHGAP36):​c.134G>T​(p.Arg45Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000578 in 1,210,405 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R45S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000061 ( 0 hom. 18 hem. )

Consequence

ARHGAP36
NM_144967.4 missense

Scores

1
1
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.328
Variant links:
Genes affected
ARHGAP36 (HGNC:26388): (Rho GTPase activating protein 36) Predicted to enable GTPase activator activity. Predicted to be involved in regulation of catalytic activity and signal transduction. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0625751).
BS2
High Hemizygotes in GnomAdExome4 at 18 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARHGAP36NM_144967.4 linkc.134G>T p.Arg45Leu missense_variant Exon 2 of 12 ENST00000276211.10 NP_659404.2 Q6ZRI8-1
ARHGAP36NM_001282607.2 linkc.98G>T p.Arg33Leu missense_variant Exon 2 of 12 NP_001269536.1 Q6ZRI8-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARHGAP36ENST00000276211.10 linkc.134G>T p.Arg45Leu missense_variant Exon 2 of 12 2 NM_144967.4 ENSP00000276211.5 Q6ZRI8-1

Frequencies

GnomAD3 genomes
AF:
0.0000267
AC:
3
AN:
112168
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34346
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000563
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000164
AC:
3
AN:
183438
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
67870
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000244
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000610
AC:
67
AN:
1098237
Hom.:
0
Cov.:
34
AF XY:
0.0000495
AC XY:
18
AN XY:
363591
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000284
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000760
Gnomad4 OTH exome
AF:
0.0000434
GnomAD4 genome
AF:
0.0000267
AC:
3
AN:
112168
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34346
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000563
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000756
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000149
AC:
1
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.0000545
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 29, 2025
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.134G>T (p.R45L) alteration is located in exon 2 (coding exon 1) of the ARHGAP36 gene. This alteration results from a G to T substitution at nucleotide position 134, causing the arginine (R) at amino acid position 45 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
2.4
DANN
Benign
0.89
DEOGEN2
Benign
0.018
T;.;.
FATHMM_MKL
Benign
0.077
N
LIST_S2
Benign
0.64
T;T;T
M_CAP
Benign
0.0034
T
MetaRNN
Benign
0.063
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
1.1
L;.;.
PrimateAI
Benign
0.32
T
PROVEAN
Benign
1.1
N;N;N
REVEL
Benign
0.026
Sift
Uncertain
0.0040
D;D;D
Sift4G
Pathogenic
0.0
D;D;.
Polyphen
0.45
B;B;B
Vest4
0.26
MVP
0.043
MPC
0.74
ClinPred
0.057
T
GERP RS
1.4
Varity_R
0.068
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs368664815; hg19: chrX-130215773; COSMIC: COSV52270111; COSMIC: COSV52270111; API